Cancer-Related Distress: Revisiting the Utility of the National Comprehensive Cancer Network Distress Thermometer Problem List in Women With Gynecologic Cancers.
Journal
JCO oncology practice
ISSN: 2688-1535
Titre abrégé: JCO Oncol Pract
Pays: United States
ID NLM: 101758685
Informations de publication
Date de publication:
08 2020
08 2020
Historique:
pubmed:
25
2
2020
medline:
25
6
2021
entrez:
25
2
2020
Statut:
ppublish
Résumé
The Distress Thermometer (DT) includes a measure of cancer-related distress and a list of self-reported problems. This study evaluated the utility of the DT problem list in identifying concerns most associated with distress and poorer quality of life (QOL) in survivors of gynecologic cancer. Demographic, clinical, psychosocial functioning, and DT data were described among 355 women participating in a gynecologic cancer cohort. Problems from the DT list were ranked by prevalence, distress, and QOL. Logistic regression models explored factors associated with problems that were common (≥ 25% prevalence) and associated with distress and QOL. The average age of participants was 59.9 years (standard deviation [SD], 10.8 years). Most participants were non-Hispanic white (97%) and had ovarian (44%) or uterine (42%) cancer. The mean DT score was 2.7 (SD, 2.7); participants reported a mean of 7.3 problems (SD, 5.9 problems). The most common problems were fatigue (53.6%), worry (49.9%), and tingling (46.3%); least common problems were childcare (2.1%), fevers (2.1%), and substance abuse (1.1%). Report of some common problems, including tingling, sleep, memory, skin issues, and appearance, was not associated with large differences in distress or QOL. In contrast, some rarer problems such as childcare, treatment decisions, eating, housing, nausea, and bathing/dressing were associated with worse distress or QOL. Younger age, lower income, and chemotherapy were risk factors across common problems that were associated with worse distress or QOL (fatigue, nervousness, sadness, fears, and pain). The DT problem list did not easily identify concerns most associated with distress and low QOL in patients with gynecologic cancer. Adaptations that enable patients to report their most distressing concerns would enhance clinical utility of this commonly used tool.
Identifiants
pubmed: 32091952
doi: 10.1200/JOP.19.00471
pmc: PMC7587428
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
e649-e659Subventions
Organisme : NCI NIH HHS
ID : P30 CA077598
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002494
Pays : United States
Références
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Cancer. 2016 Apr 15;122(8):283-9
pubmed: 26991528
Pediatr Blood Cancer. 2008 Jan;50(1):104-10
pubmed: 17554791
Psychooncology. 2018 Dec;27(12):2740-2746
pubmed: 30171792
Cancer. 2014 Oct 15;120(20):3245-53
pubmed: 24954526
Support Care Cancer. 2017 Jun;25(6):1897-1904
pubmed: 28150043
Cancer. 2012 Nov 15;118(22):5671-8
pubmed: 22517236
J Clin Oncol. 2005 Aug 1;23(22):5155-65
pubmed: 16051957
Health Soc Work. 2011 Nov;36(4):293-7
pubmed: 22308881
Cancer. 1998 May 15;82(10):1904-8
pubmed: 9587123
Cancer. 2005 Apr 1;103(7):1494-502
pubmed: 15726544
Aust J Rural Health. 2009 Dec;17(6):298-304
pubmed: 19930195
J Obstet Gynecol Neonatal Nurs. 2008 Nov-Dec;37(6):640-6
pubmed: 19012714
Psychooncology. 2012 Jun;21(6):588-93
pubmed: 22438289
Cancer. 2018 Jun 15;124(12):2629-2636
pubmed: 29732554
Oncol Nurs Forum. 2009 Mar;36(2):175-83
pubmed: 19273406
Cancer. 2015 Oct 1;121(19):3499-506
pubmed: 26214755
J Natl Compr Canc Netw. 2010 Apr;8(4):487-94
pubmed: 20410338
Palliat Support Care. 2014 Feb;12(1):75-80
pubmed: 24169263
Acta Oncol. 2013 Feb;52(2):216-24
pubmed: 23320770
J Affect Disord. 2012 Dec 10;141(2-3):343-51
pubmed: 22727334
J Community Health. 2013 Oct;38(5):976-93
pubmed: 23543372
Eur J Cancer Care (Engl). 2011 Nov;20(6):738-46
pubmed: 21481049
Psychooncology. 2018 May;27(5):1394-1403
pubmed: 29315955
J Natl Cancer Inst. 2012 Mar 7;104(5):386-405
pubmed: 22271773
Palliat Med. 2017 Mar;31(3):231-238
pubmed: 27484674
J Natl Cancer Inst. 2015 Dec 11;108(5):
pubmed: 26657334
Support Care Cancer. 2016 Nov;24(11):4549-57
pubmed: 27260016
Lung Cancer. 2007 Feb;55(2):215-24
pubmed: 17084483
J Natl Compr Canc Netw. 2013 Feb 1;11(2):190-209
pubmed: 23411386
Psychol Health. 2014;29(6):651-70
pubmed: 24410202
J Natl Compr Canc Netw. 2007 Jan;5(1):3-7
pubmed: 17323529
Cancer. 2008 Feb 1;112(3):616-25
pubmed: 18085642
Br J Nurs. 2011 Feb 24-Mar 9;20(4):220-7
pubmed: 21471860
Psychooncology. 2018 Jan;27(1):75-82
pubmed: 28568377
Crit Rev Oncol Hematol. 2011 Feb;77(2):109-30
pubmed: 20117019
J Oncol Pract. 2010 Mar;6(2):69-73
pubmed: 20592778
J Oncol Pract. 2014 Sep;10(5):332-8
pubmed: 24865220
J Sex Med. 2012 Feb;9(2):361-71
pubmed: 22082135
Psychooncology. 2006 Jul;15(7):647-9
pubmed: 16817171
Pflege. 2018 Aug;31(4):191-202
pubmed: 29592536
Crit Rev Oncol Hematol. 2004 Jan;49(1):37-42
pubmed: 14734153
J Clin Oncol. 1993 Mar;11(3):570-9
pubmed: 8445433
Int J Gynecol Cancer. 2004 Sep-Oct;14(5):875-81
pubmed: 15361198
J Behav Med. 2018 Apr;41(2):243-252
pubmed: 28983735
J Adv Nurs. 2005 Oct;52(1):38-46
pubmed: 16149979
Am J Clin Oncol. 2001 Dec;24(6):591-6
pubmed: 11801761
J Clin Oncol. 2003 Dec 1;21(23 Suppl):253s-265s
pubmed: 14645405
J Adv Nurs. 2002 Sep;39(5):500-9
pubmed: 12175360
Psychosomatics. 2018 Sep - Oct;59(5):464-471
pubmed: 29525522
Gynecol Oncol. 2013 Apr;129(1):234-40
pubmed: 23290987
Psychooncology. 2009 Jan;18(1):1-5
pubmed: 19097139
Gynecol Oncol. 2000 Apr;77(1):73-7
pubmed: 10739693
Support Care Cancer. 2015 May;23(5):1225-32
pubmed: 25315367
J Natl Compr Canc Netw. 2019 Oct 1;17(10):1229-1249
pubmed: 31590149